Amy K. Dow
FDA Issues Final Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors
Health Care and Life Sciences ·
Anti-Abortion Advocacy Groups’ Challenge to FDA-Approved Abortion Pill May Have Far-Reaching Consequences
Food, Drug & Agriculture ·
In Response to COVID-19, FDA Extends Enforcement Discretion for HCT/Ps Requiring Pre-Market Review
Health Care and Life Sciences ·
In Response to COVID-19, FDA Extends Enforcement Discretion for HCT/Ps Requiring Pre-Market Review
Health Care and Life Sciences ·